THE GREATEST GUIDE TO MCC950 ATHEROSCLEROSIS

expression, which can be a essential driver of NIH. In an in vivo mouse product of NIH in vascular grafts, MCC950 drastically enhanced re‐endothelialization and decreased NIH compared to PTX or SMS.Major dissimilarities happened at day 28 only in grafts treated with MCC950 which showed an average 57% lessen in total macrophages in comparison with